Last reviewed · How we verify
Vaccinia virus: ACAM2000 smallpox vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Vaccinia virus: ACAM2000 smallpox vaccine (Vaccinia virus: ACAM2000 smallpox vaccine) — Emergent BioSolutions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vaccinia virus: ACAM2000 smallpox vaccine TARGET | Vaccinia virus: ACAM2000 smallpox vaccine | Emergent BioSolutions | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vaccinia virus: ACAM2000 smallpox vaccine CI watch — RSS
- Vaccinia virus: ACAM2000 smallpox vaccine CI watch — Atom
- Vaccinia virus: ACAM2000 smallpox vaccine CI watch — JSON
- Vaccinia virus: ACAM2000 smallpox vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Vaccinia virus: ACAM2000 smallpox vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/vaccinia-virus-acam2000-smallpox-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab